Hodgkin lymphoma trials in Serbia

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Where

  Belgrade, Kamenitz, Kragujevac, Niš

  Age

  18 years and over

  People

  386 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT05645107 · EU 2022-502193-16-00